Rainbow Childrens Medicare Ltd.

“Rainbow is India's only listed pure-play pediatric hospital chain, earning ~20% ROCE on a long reinvestment runway with a genuinely durable moat built on NICU capital intensity, specialist physician scarcity, and 25 years of brand trust. The business is not impaired and the growth story is intact. However, at 42x forward earnings the stock prices in flawless geographic expansion with no room for execution slippage, demographic headwinds in South India, or regulatory price controls — the base-case 10-year return is approximately 2x (~7% CAGR), which is inadequate compensation for the embedded risks. The correct posture is to track for a meaningful price correction toward the 30-32x forward earnings range before initiating or meaningfully adding.”